Pauline Evers
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 4
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Jens Atzpodien (3 shared papers)M. Hadam (3 shared papers)R. Oskam (2 shared papers)Peter Palmer (2 shared papers)C.R. Franks (2 shared papers)Gerda Roest (2 shared papers)Michelle Hendriks (1 shared paper)Marieke Zegers (1 shared paper)
- Journals
- BMC Cancer (2 papers)Cancer Letters (1 paper)Cancer (1 paper)European Journal of Cancer (1 paper)Human Genetics (1 paper)
- Partner nations
- NetherlandsGermanyPortugal
In The Last Decade
Pauline Evers
10 papers receiving 272 citations
Peers
Comparison fields: 5 of 56
- Immunology 112
- Oncology 127
- Surgery 60
- Pulmonary and Respiratory Medicine 41
- Pathology and Forensic Medicine 20
Countries citing papers authored by Pauline Evers
This map shows the geographic impact of Pauline Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pauline Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pauline Evers more than expected).
Fields of papers citing papers by Pauline Evers
This network shows the impact of papers produced by Pauline Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pauline Evers. The network helps show where Pauline Evers may publish in the future.
Co-authors
The 25 scholars most cited alongside Pauline Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 56 | |
| 2 | Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study. | 1990 | 51 |
| 3 | 1993 | 47 | |
| 4 | 2013 | 39 | |
| 5 | 1985 | 25 | |
| 6 | Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience. | 1990 | 23 |
| 7 | 1991 | 20 | |
| 8 | 2019 | 20 | |
| 9 | 2014 | 6 | |
| 10 | 1985 | 1 |
About Pauline Evers
Pauline Evers is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Surgery, having authored 10 papers that have together received 288 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (2 papers), Intellectual Property and Patents (1 paper), Intraperitoneal and Appendiceal Malignancies (1 paper), Glycosylation and Glycoproteins Research (1 paper), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper), Patient Satisfaction in Healthcare (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Immunology (112 citations), Oncology (127 citations), Surgery (60 citations), Pulmonary and Respiratory Medicine (41 citations) and Pathology and Forensic Medicine (20 citations). Pauline Evers has collaborated with scholars based in Netherlands, Germany and Portugal. Frequent co-authors include Jens Atzpodien, M. Hadam, R. Oskam, Peter Palmer, C.R. Franks, Gerda Roest, Michelle Hendriks, Marieke Zegers, Diana Delnoij and Jany JDJM Rademakers. Their work appears in journals such as BMC Cancer, Cancer Letters, Cancer, European Journal of Cancer and Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.